Atlas Trials

A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis

Clinical trial NCT06786507 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06786507
Sponsor
Helwan University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Ulcerative Colitis (UC)
Start date
2025-05-15
Primary completion
2026-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.